Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept study of Xeomin versus Dysport for treatment of crow's feet
2008-001157-18Phase 2Completed
- Sponsor
- Dermatologikum Hamburg
- Start
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in rhytides (2 arms), sponsored by Dermatologikum Hamburg. Primary endpoint: Global assessment of crow's feet by Facial Wrinkle Scale (laughing condition). Started Apr 2008; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on 2008-001157-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001157-18.